Results 21 to 30 of about 993,013 (333)

A Study of Hepatocellular Carcinoma in Chronic Hepatitis C Patients Received Direct Acting Antiviral Drugs [PDF]

Al-Azhar International Medical Journal, 2020
Background: infection with hepatitis c poses a global health problem that affect 200 million chronically infected patients globally. infected patients with hepatitis c virus (HCV)run high risk of developing fibrosis, cirrhosis and hepatocellular ...
Wael Hablas, Arafat Qasem, Magdy El Dahshan, Moataz Mousa   +3 more
doaj   +1 more source

lncRNA-AC079061.1/VIPR1 axis may suppress the development of hepatocellular carcinoma: a bioinformatics analysis and experimental validation

Journal of Translational Medicine, 2022
Background Hepatocellular carcinoma (HCC) is one of the most malignant tumors to threaten human life, and the survival rate remains low due to delayed diagnosis.
Xia-Hui Lin, Dan-Ying Zhang, Zhi-Yong Liu, Wen-qing Tang, Rong-Xin Chen, Dong-ping Li, Shuqiang Weng, Ling Dong   +7 more
doaj   +1 more source

Expression and Clinical Significance of miRNA-152 in Hepatocellular Carcinoma

Zhongliu Fangzhi Yanjiu, 2021
Objective To investigate the expression of microRNA-152 in hepatocellular carcinoma, and analyze the correlation of miR-152 expression with the clinicopathological characteristics of hepatocellular carcinoma(HCC) patients.
PENG Qiliu, WEI Shangmou, ZHANG Lei, GAN Liying, XIE Zhen, CHEN Qiaopei, WEI Bangning, ZHANG Zhi   +7 more
doaj   +1 more source

Interferon-induced transmembrane protein 3 in hepatocellular carcinoma patients

BMC Cancer, 2023
Objective The study aimed to investigate the over expression of IFITM3 in hepatocellular carcinoma Egyptian patients. Background Hepatocellular carcinoma (HCC) continues to be a serious disease burden.
Rania M. Bondok, Lamiaa A. Barakat, Alyaa R. Elsergany, Nancy Mahsoub, Maivel H. Ghattas   +4 more
doaj   +1 more source

Anti-angiogenesis in hepatocellular carcinoma treatment : current evidence and future perspectives [PDF]

, 2011
Hepatocellular carcinoma (HCC) is among the most common cancer diseases worldwide. Arterial hypervascularisation is an essential step for HCC tumorigenesis and can be targeted by transarterial chemoembolization (TACE).
Trojan, Jörg, Welker, Martin-Walter
core   +1 more source

Imaging of Hepatocellular Carcinoma by Computed Tomography and Magnetic Resonance Imaging: State of the Art [PDF]

, 2009
Hepatocellular carcinoma (HCC) is a very frequent tumor worldwide. Its incidence is linked to the distribution of liver cirrhosis and viral hepatitis, which are the main risk factors for the development of HCC.
Reiser, Maximilian F., Herrmann, Karin A., Zech, Christoph J.   +2 more
core   +1 more source

Chemoembolization combined with pravastatin improves survival in patients with hepatocellular carcinoma [PDF]

, 2008
BACKGROUND/AIMS: Pravastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, has been shown to inhibit growth and to induce apoptosis in human hepatocellular carcinoma (HCC) cells.
Straub, Gundula, Dogan, Selin, Göke, Burkhard, Dogan, S, Seidel, D, Walli, Autar, Graf, H, Jakobs, T, Hoffmann, Ralf-Thorsten, Reiser, Maximilian F., Straub, G, Juengst, Christoph, Reiser, M, Walli, A, Hoffmann, R T, Walter, A, Seidel, Dietrich, Jüngst, C, Waggershauser, T, Jüngst, D, Göke, B, Walter, Andreas, Graf, Hannah, Helmberger, Thomas, Jakobs, Tobias, Juengst, Dieter, Helmberger, T, Waggershauser, Tobias   +27 more
core   +1 more source

HNF-4α inhibits hepatocellular carcinoma cell proliferation through mir-122-adam17 pathway.

PLoS ONE, 2020
Hepatocellular carcinoma (HCC) is one of the most common human cancers, its prevalence and severity need us to discover novel early diagnostic biomarkers and new therapeutic strategies. MicroRNA-122 is the most abundant microRNA in the liver, and acts as
Guang Yang, Min Zhang, Yawei Zhao, Yue Pan, Mujie Kan, Jing Li, Kan He, Xuewen Zhang   +7 more
doaj   +1 more source

Association between serum midkine levels and tumor size in Indonesian hepatocellular carcinoma patients: a cross-sectional study

Romanian Journal of Internal Medicine, 2022
Background: The incidence of liver cancer is increased worldwide with 75%–85% diagnosed as hepatocellular carcinoma (HCC). Current practice has low sensitivity limitations to diagnose the early stages of HCC, thus urging the need for a biomarker with ...
Darmadi Darmadi, Ruslie Riska Habriel, Pakpahan Cennikon   +2 more
doaj   +1 more source

Multimodality Treatment with Conventional Transcatheter Arterial Chemoembolization and Radiofrequency Ablation for Unresectable Hepatocellular Carcinoma [PDF]

, 2011
Background/Aims: To evaluate the efficacy of multimodality treatment consisting of conventional transcatheter arterial chemoembolization (TACE) and radiofrequency ablation (RFA) in patients with non-resectable and non-ablatable hepatocellular carcinoma ...
Rentsch, M., P. Paprottka, F.T. Kolligs, M. Rentsch, Paprottka, P., T.F. Jakobs, Kolligs, F. T., Reiser, Maximilian F., Jakobs, T. F., Ashoori, N., F. Bamberg, Bamberg, F., Trumm, C., N. Ashoori, C. Trumm, M.F. Reiser   +15 more
core   +1 more source